Companies: 10,795·Total market cap: $144.5T
Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc.

IMDXNASDAQHealthcare● Active
$5.98
+$0.26(+4.60%)
Market Cap$160592473
P/E Ratio
52W High$8.51
52W Low$2.33
Overview

Insight Molecular Diagnostics Inc.(IMDX)· 资产负债表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · IMDX · 截至 2026-06-10

财务报表

Total Assets · Total Liabilities · Equity
Breakdown2025-122024-122023-122022-122021-12
Assets
Cash & ST Investments$11.58M$8.64M$9.43M$20.43M$33.85M
Net Receivables$1.13M$1.61M$0.48M$2.01M$1.44M
Inventory$0.45M$0.41M$0.00M$0.00M$0.30M
Total Current Assets$15.31M$11.76M$10.70M$25.54M$39.14M
PP&E Net$2.81M$2.76M$5.44M$10.85M$8.37M
Goodwill$0.00M$0.00M$0.00M$0.00M$18.68M
Intangible Assets$0.00M$14.61M$56.59M$61.63M$61.72M
Total Assets$25.76M$35.08M$74.89M$100.09M$159.56M
Liabilities
Short-Term Debt$1.81M$0.00M$0.00M$0.00M$1.31M
Accounts Payable$2.54M$2.28M$0.95M$1.25M$1.81M
Total Current Liabilities$12.07M$7.28M$7.19M$12.11M$14.12M
Long-Term Debt$0.00M$0.00M$0.00M$0.00M$0.00M
Total Liabilities$57.22M$47.35M$54.42M$60.50M$94.35M
Stockholders Equity
Retained Earnings($400.76M)($350.54M)($289.88M)($260.68M)($187.77M)
Total Stockholders Equity($31.46M)($12.27M)$20.47M$39.59M$65.22M
Total Liab & Equity(computed)$25.76M$35.08M$74.89M$100.09M$159.56M
Debt Summary
Total Debt$3.50M$3.66M$2.87M$3.54M$5.68M
Net Debt($8.09M)($4.97M)($6.56M)($16.45M)($27.27M)

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · USD · M

深入了解Insight Molecular Diagnostics Inc.

关于Insight Molecular Diagnostics Inc.(IMDX)资产负债表

Insight Molecular Diagnostics Inc.总资产$0.03B,现金及短期投资$0.01B,总负债$0.06B,总债务$0.00B,股东权益($0.03B)。

常见问题

IMDX · 4 问

Insight Molecular Diagnostics Inc.总债务$0.00B,净债务($0.01B)。

IMDX total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10